A potassium blood test measures the potassium concentration in the fluid part of your blood, which is a tightly regulated figure rather than a tally of dietary intake. At Longevity Benchmark, we review metabolic test panels to clarify what blood measurements reflect about organ function. There is no single national reference band. Mayo Clinic Laboratories publishes 3.6 to 5.2 mmol/L for ages one year and older, the Association for Diagnostics and Laboratory Medicine (ADLM) cites 3.5 to 5.5 mmol/L, and a 2026 survey of 60 laboratories found lower limits ranging from 3.2 to 3.7 mmol/L and upper limits from 4.5 to 5.5 mmol/L. The band that applies to you is the one printed on your own report.
The Verdict
Identification and Reference Intervals on Laboratory Reports
Serum potassium measures the concentration of potassium ions in the liquid portion of the blood. According to MedlinePlus, the test is part of an electrolyte panel and is also included in the basic metabolic panel and the comprehensive metabolic panel. Most automated clinical chemistry analysers quantify this ion using indirect potentiometry with ion-selective electrodes.
Reference bands differ between institutions and sample types. A 2026 survey of 60 laboratories published by Hortin and colleagues in the Journal of Applied Laboratory Medicine found lower limits from 3.2 to 3.7 mmol/L and upper limits from 4.5 to 5.5 mmol/L. The three most common intervals were 3.5 to 5.1, 3.5 to 5.2, and 3.5 to 5.3 mmol/L.
Sample matrix alters the reported number. Hortin and colleagues reported that plasma usually reads 0.2 to 0.4 mmol/L lower than serum, an average gap of about 0.3 mmol/L. That gap exceeds the acceptable analytical bias of about 0.10 to 0.15 mmol/L. Even so, 41 of the 60 surveyed laboratories applied the same interval to both tube types. When evaluating critically ill patients, direct whole-blood potentiometry on blood gas analysers averaged 3.8 mmol/L against 4.124 mmol/L in serum indirect potentiometry, showing an estimated mean difference of 0.32 mmol/L.
| Source or Matrix | Reported Reference Band | Operational Notes |
|---|---|---|
| Mayo Clinic Laboratories (Test ID KS) | 3.6 to 5.2 mmol/L | Applies to serum samples for ages one year and older. |
| Association for Diagnostics and Laboratory Medicine | 3.5 to 5.5 mmol/L | Standard adult educational reference interval for serum or plasma. |
| Survey of 60 Clinical Laboratories (JALM 2026) | Lower limits: 3.2 to 3.7 mmol/L; Upper limits: 4.5 to 5.5 mmol/L | Most common published intervals were 3.5 to 5.1, 3.5 to 5.2, and 3.5 to 5.3 mmol/L. |
| Heparinized Plasma Matrix | 0.2 to 0.4 mmol/L lower than serum | Average difference is roughly 0.3 mmol/L across clinical chemistry systems. |
| Whole Blood Arterial Gas Analysers | Direct potentiometry mean: 3.80 mmol/L | Measured lower than serum indirect potentiometry (mean difference 0.32 mmol/L). |
Cellular Distribution and the Transcellular Gradient
Serum carries only a small share of the body's potassium. StatPearls puts the concentration inside cells at about 140 mEq/L against 4 to 5 mEq/L outside them, with total body stores of 50 to 75 mEq per kilogram of body weight, roughly 3,000 mEq in an adult. This concentration gradient maintains cellular resting membrane potentials.
Transcellular distribution shifts potassium without altering total body reserves. Beta-2-adrenergic receptors and insulin drive potassium into cells by increasing the activity of the sodium-potassium adenosine triphosphatase pump. An inhaled beta-agonist or an insulin surge lowers circulating potassium quickly by shifting it across cell membranes.
Biological Drivers of High Potassium
Hyperkalemia develops when renal excretion falls, transcellular shifts move ions out of cells, or tissue damage releases cellular stores. In the distal nephron, aldosterone enhances sodium uptake. This creates luminal electronegativity that facilitates potassium excretion via an electrical gradient. StatPearls states that elevations in serum potassium typically do not occur until the glomerular filtration rate declines below 30 mL/min.
Renal disease impairs this clearance. In chronic kidney disease patients with a mean eGFR of 14.6 mL/min/1.73 m2, one study reported a 40% prevalence of serum potassium above 5.5 mmol/L. A prospective study of over 2,000 chronic kidney disease patients in nephrology care demonstrated a hyperkalemia prevalence of 37%.
Medications frequently disrupt renal elimination. Renin-angiotensin-aldosterone system inhibitors increase the frequency and degree of hyperkalemia. These medications include angiotensin-converting enzyme inhibitors such as captopril, enalapril, and lisinopril; angiotensin receptor blockers such as candesartan and losartan; and aldosterone antagonists such as spironolactone and eplerenone. StatPearls also names potassium-sparing diuretics, nonsteroidal anti-inflammatory drugs, and digoxin as disruptive agents.
Acid-base disturbances also push potassium into serum. In mineral metabolic acidosis, acidic extracellular pH affects cellular transporters, leading to relative sequestration of potassium ions in extracellular fluid. You can review how bicarbonate balances this process in our guide to the CO2 blood test. MedlinePlus also lists Addison disease, uncontrolled type 1 diabetes, injuries, burns, surgery, and excessive intake of potassium-rich food as causes of high serum potassium.
Age alters baseline distributions. In a study of 20,667 emergency department patients, serum potassium rose with age, independent of diuretic medication. Hyperkalemia prevalence rose from 0.8% in patients aged 16 to 21 to 10.4% in patients over 80.
Biological Drivers of Low Potassium
Hypokalemia occurs when urinary excretion increases, gastrointestinal losses mount, or circulating ions shift into cells. StatPearls defines hypokalemia as serum potassium below 3.5 mmol/L. It grades severity as mild at 3.0 to 3.4 mmol/L, moderate at 2.5 to 3.0 mmol/L, and severe at less than 2.5 mmol/L.
Renal and gastrointestinal wasting represent the most common paths to depletion. StatPearls lists loop diuretics, thiazide diuretics, insulin injection, beta-adrenergic inhalation, alkalosis, and hypomagnesaemia among the causes. For a wider look at electrolyte balance, read our review of serum chloride. MedlinePlus also cites fluid loss from diarrhoea, vomiting, sweating, laxative overuse, adrenal disorders, kidney disease, alcohol use disorder, and low dietary intake.
Low-normal concentrations carry clinical associations in hypertensive cohorts. The LIFE trial followed 8,586 hypertensive patients. Those in the lowest baseline potassium quartile, at or below 3.90 mEq/L, had a 24% higher risk of Cornell product left ventricular hypertrophy exceeding 2440 mm*ms (odds ratio 1.24, 95% confidence interval 1.11 to 1.38, p < 0.001).
Clinical Severity Bands and Electrocardiographic Signatures
Clinical symptoms and electrocardiographic changes emerge as potassium concentrations move away from the reference interval. The ADLM module notes that concentrations below 6.5 mmol/L are typically asymptomatic. Urgent reduction is indicated if potassium exceeds 7.0 mmol/L or significant electrocardiographic changes are present.
Mortality tracks the circulating value continuously. In chronic kidney disease cohorts, mortality risk increases when potassium exceeds 5.0 mmol/L, rises further between 5.5 and 6.0 mmol/L, and reaches its highest level above 6.0 mmol/L. The UK Kidney Association defines hyperkalaemia as 5.5 mmol/L or greater, splitting severity into mild (5.5 to 5.9 mmol/L), moderate (6.0 to 6.4 mmol/L), and severe (6.5 mmol/L or higher).
Physical symptoms remain non-specific and typically arrive late. StatPearls notes that patients may report weakness, fatigue, palpitations, or syncope. Physical examinations may reveal generalized muscle weakness, flaccid paralysis, or depressed deep tendon reflexes. For low potassium, clinical symptoms are inapparent until levels fall below 3.0 mmol/L, with significant muscle weakness developing below 2.5 mmol/L.
| Serum Potassium Band | Clinical Classification | Electrocardiogram Findings | Reported Symptoms and Clinical Guidance |
|---|---|---|---|
| Below 3.5 mmol/L | Hypokalemia: mild 3.0 to 3.4, moderate 2.5 to 3.0, severe below 2.5 (StatPearls) | StatPearls describes decreased T wave amplitude, depressed ST segment, U wave appearance, and prolonged QT interval | Symptoms are absent above 3.0 mmol/L; significant muscle weakness occurs below 2.5 mmol/L. |
| Within lab band | Baseline reference interval (lower limits 3.2 to 3.7, upper limits 4.5 to 5.5 across 60 labs) | Normal cardiac conduction | Represents normal homeostatic balance on your laboratory report. |
| 5.5 to 5.9 mmol/L | Mild hyperkalaemia (UK Kidney Association) | Tall, peaked T waves (StatPearls maps these to 5.5 to 6.5 mmol/L) | Typically asymptomatic; investigated through prescription review and kidney function markers. |
| 6.0 to 6.4 mmol/L | Moderate hyperkalaemia (UK Kidney Association) | Tall, peaked T waves; progressive conduction slowing | The UK Kidney Association classes this band as moderate hyperkalaemia. |
| 6.5 to 7.4 mmol/L | Severe hyperkalaemia (UK Kidney Association: 6.5 mmol/L or higher) | Flattening or loss of P waves (6.5 to 7.5 mmol/L); QRS widening (7.0 to 8.0 mmol/L) | StatPearls notes concentrations below 6.5 mmol/L are typically asymptomatic, but severe bands warrant immediate evaluation. |
| 7.0 mmol/L or higher | Severe hyperkalaemia requiring acute reduction | Severe arrhythmias, sine-wave pattern, and potential progression to asystole (8.0 to 10.0 mmol/L) | The ADLM states that urgent reduction is indicated above 7.0 mmol/L or where significant ECG changes are present. |
Testing Preparation and Specimen Handling
Fasting instructions depend entirely on whether other tests share your blood draw. MedlinePlus states that you do not need special preparations for an isolated potassium blood test or an electrolyte panel. When potassium is drawn as part of a panel, MedlinePlus says a comprehensive metabolic panel may require several hours of fasting, which comes from the glucose and lipid lines on the panel rather than from potassium.
A high potassium can also be an artefact of how the sample was drawn and handled rather than a change in the body, which we cover in our guide to false high potassium results.
Sample storage conditions alter analytical results. StatPearls notes that hyperkalemia occurs in fewer than 5% of individuals worldwide, but reaches up to 10% in hospitalized patients. Ambulatory outpatients showing an isolated elevation without symptoms or kidney disease frequently undergo a redraw to confirm the value.
Dietary Potassium and Preventative Screening Panels
Potassium has no lower is better direction. The band exists because cardiac conduction depends on the concentration, so a result is read for whether it sits inside the band, not for how far below the middle it sits. In our discussion of normal versus optimal biomarkers, we separate functional ranges from markers that require strict balance.
Dietary intake provides the raw input for whole-body stores. The Food and Drug Administration sets the adult Daily Value for potassium at 4,700 mg. Potassium is one of four nutrients whose actual amount and percent Daily Value must appear on Nutrition Facts labels.
Population trials show cardiovascular benefits from dietary potassium substitution in specific groups. In the Salt Substitute and Stroke Study, researchers randomized 600 villages in rural China. They assigned 10,504 individuals to a salt substitute comprising 75% sodium chloride and 25% potassium chloride, and 10,491 individuals to regular salt. Salt substitute users experienced reduced stroke (relative risk 0.86, 95% CI 0.77 to 0.96), lower major adverse cardiovascular events (relative risk 0.87, 95% CI 0.80 to 0.94), and lower all-cause mortality (relative risk 0.88, 95% CI 0.82 to 0.95).
The trial found no difference in hyperkalemia between groups, with a relative risk of 1.04 (95% CI 0.80 to 1.37). However, the study explicitly excluded people who used potassium-sparing diuretics or had serious kidney disease. Renal guidelines set restricted potassium intakes for people with recurrent hyperkalaemia at 5.5 mmol/L or above, but that restriction is prescribed and monitored by a renal team, and the figure is not a target for anyone else. Diet changes around potassium belong with the clinician who holds your kidney results.
Clinical Confirmation and Diagnostic Workup
StatPearls states that serum potassium elevations in asymptomatic patients without characteristic ECG changes should be confirmed before aggressive intervention, and that the workup includes serum creatinine, BUN, urinalysis, and a complete blood count. Whether your own result needs repeating is a judgement your clinician makes with your kidney function and medicines in view.
An electrocardiogram provides valuable electrical context, but it cannot rule out hyperkalemia on its own. American Family Physician notes that about one half of patients with potassium levels exceeding 6.0 mEq/L have a normal electrocardiogram. A clinician will not dismiss a laboratory elevation simply because a rhythm strip looks clear.
Any potassium result outside your laboratory's printed band belongs with the clinician who ordered it, whatever the number. The ADLM states that urgent reduction is indicated above 7.0 mmol/L or with significant ECG changes; that judgement is made by a clinician with your history, your medicines and an ECG in front of them, not from the number alone.
Frequently Asked Questions
What does a potassium blood test tell you?
A potassium blood test measures the concentration of potassium in the liquid portion of your blood. It assesses whether circulating potassium sits within the safe physiological band required for normal cardiac rhythm and muscle contraction. Most of the body's potassium resides inside cells, where StatPearls puts the concentration at roughly 140 mEq/L compared to 4 to 5 mEq/L in serum. Total body stores equal 50 to 75 mEq per kilogram of body weight, or about 3,000 mEq in an adult. Because the blood test measures only extracellular potassium, it reflects immediate homeostatic balance rather than total body reserves.
What is the normal range for a potassium blood test?
No single adult reference band applies nationally. Mayo Clinic Laboratories publishes 3.6 to 5.2 mmol/L for ages one year and older. The Association for Diagnostics and Laboratory Medicine cites 3.5 to 5.5 mmol/L as a typical reference interval. A 2026 survey of 60 laboratories found lower limits spanning 3.2 to 3.7 mmol/L and upper limits ranging from 4.5 to 5.5 mmol/L, with the three most common intervals being 3.5 to 5.1, 3.5 to 5.2, and 3.5 to 5.3 mmol/L. Plasma samples typically run 0.2 to 0.4 mmol/L lower than serum.
What is potassium called on a blood test?
On diagnostic laboratory reports, potassium prints under its chemical abbreviation K. You will find it listed within electrolyte panels, basic metabolic panels, and comprehensive metabolic panels. The reported value is typically measured in millimoles per liter (mmol/L) or milliequivalents per liter (mEq/L), which represent equivalent numerical values for potassium. A laboratory report will list your numerical result directly beside the specific reference interval established by that testing facility.
Do you need to fast for a potassium blood test?
You do not need to fast for an isolated potassium blood test or an electrolyte panel. According to MedlinePlus, there are no special dietary preparations required for the potassium measurement itself. However, potassium is frequently ordered as part of a basic or comprehensive metabolic panel that measures fasting glucose and lipid markers. MedlinePlus notes that a comprehensive metabolic panel may require several hours of fasting beforehand. When fasting is requested for a combined blood draw, the instruction originates from those co-ordered tests rather than the potassium assay.
What does a high potassium blood test mean?
A high potassium blood test, termed hyperkalemia, indicates that circulating potassium exceeds your laboratory's reference range. Common clinical drivers include reduced kidney clearance, as StatPearls notes that serum potassium elevations typically appear once glomerular filtration declines below 30 mL/min. Medications such as ACE inhibitors, ARBs, and spironolactone also impair clearance. Acidosis, uncontrolled type 1 diabetes, and tissue trauma can drive ions out of cells. A high reading can also be an artefact of collection rather than a real elevation, which a clinician establishes with a carefully drawn repeat.
What causes low potassium on a blood test?
Low potassium, known as hypokalemia, occurs when serum concentrations fall below 3.5 mmol/L. StatPearls identifies prescription loop and thiazide diuretics, insulin administration, beta-adrenergic inhalation, alkalosis, and hypomagnesaemia as major contributors. MedlinePlus also lists fluid loss from prolonged vomiting, severe diarrhoea, excessive sweating, laxative overuse, adrenal conditions, kidney disease, alcohol use disorder, and inadequate dietary intake. When hypomagnesaemia is present, it disrupts normal cellular potassium regulation, so clinicians frequently evaluate magnesium alongside low potassium findings.
Which blood test shows potassium?
Potassium appears on several routine blood tests. It is a standard component of an electrolyte panel, a basic metabolic panel (BMP), and a comprehensive metabolic panel (CMP). It can also be ordered as an individual serum potassium test when monitoring known electrolyte disturbances or tracking medications that alter kidney filtration. Clinicians also measure potassium directly in whole-blood samples using arterial or venous blood gas analysers in urgent hospital settings.
Is potassium on a CBC or a metabolic panel?
Potassium is on a metabolic panel, not a complete blood count (CBC). A CBC evaluates cellular blood elements, including red blood cells, white blood cells, and platelets. Metabolic panels, such as the basic metabolic panel or comprehensive metabolic panel, measure dissolved chemical markers, electrolytes, and waste products in the fluid portion of your blood. Potassium is listed alongside electrolytes like sodium, chloride, and bicarbonate on those metabolic reports.